DC2.4 Cells
USD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The DC2.4 cell line is an immortalized mouse dendritic cell line that originates from bone marrow. It is commonly used to study dendritic cell (DC) biology, immune responses, and the development of immunotherapies. DC2.4 cells are characterized by their role as antigen-presenting cells (APCs) and are known to express typical surface markers of dendritic cells, such as CD11c and MHC class I molecules. However, they exhibit an immature phenotype under standard culture conditions, with low expression of MHC class II and costimulatory molecules like CD40 and CD80. This makes them useful for investigating the mechanisms and stimuli required for DC maturation and their subsequent immune functions. Studies have shown that specific stimuli can induce maturation of DC2.4 cells. Notably, exposure to interferon-gamma (IFN-γ) leads to significant upregulation of MHC class II, CD40, CD80, and CCR7, as well as increased cytokine secretion, including IL-6, IL-12, and TNF-α. IFN-γ-matured DC2.4 cells have been demonstrated to effectively activate CD8+ cytotoxic T cells both in vitro and in vivo, enhancing antitumor immunity. For instance, IFN-γ-treated, antigen-pulsed DC2.4 cells have been shown to induce robust CD8+ T cell responses and provide protective antitumor effects in mouse models. This highlights the cell line's utility in cancer immunotherapy research and vaccine development. Additionally, DC2.4 cells have been employed to study host-pathogen interactions, as their response to various immune challenges can mimic aspects of the innate immune system's activation. The analysis of exosomal miRNA profiles from DC2.4 cells, especially when infected with pathogens like Toxoplasma gondii, has provided insights into the molecular mechanisms underlying dendritic cell signaling and immune communication. The differential expression of exosomal miRNAs in response to infection suggests potential roles in modulating host immunity and highlights the utility of DC2.4 in exosome and RNA-based immune research. |
|---|---|
| Organism | Mouse |
| Tissue | Bone marrow |
| Synonyms | DC 2.4 |
Characteristics
| Breed/Subspecies | C57BL/6 |
|---|---|
| Age | Unspecified |
| Gender | Unspecified |
| Cell type | Dendritic cell |
| Growth properties | Adherent |
Regulatory Data
| Citation | DC2.4 (Cytion catalog number 305515) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10090 |
| CellosaurusAccession | CVCL_J409 |
| GMO Status | GMO-S1: This murine dendritic cell line (DC2.4) contains retroviral constructs encoding murine GM-CSF, v-myc and v-raf introduced by transduction, supporting transformation and growth. The inserts are stably present in the dendritic cell-derived line. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Viruses | Transformant: Recombinant retrovirus J2 |
|---|
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS, 1% NEAA and 10mM HEPES |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305515-111124 | Certificate of Analysis | 23. May. 2025 | 305515 |
| 305515-240226 | Certificate of Analysis | 27. Mar. 2026 | 305515 |
| 305515-050625 | Certificate of Analysis | 21. Jul. 2025 | 305515 |